SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001193125-21-191326
Filing Date
2021-06-15
Accepted
2021-06-15 17:30:03
Documents
14
Period of Report
2021-06-03
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K/A d192569d8ka.htm   iXBRL 8-K/A 39858
2 EX-3.1 d192569dex31.htm EX-3.1 6755
6 GRAPHIC g192569snap2.jpg GRAPHIC 4884
  Complete submission text file 0001193125-21-191326.txt   192481

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA vrdn-20210603.xsd EX-101.SCH 2745
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE vrdn-20210603_lab.xml EX-101.LAB 18828
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vrdn-20210603_pre.xml EX-101.PRE 11831
7 EXTRACTED XBRL INSTANCE DOCUMENT d192569d8ka_htm.xml XML 4513
Mailing Address 6200 LOOKOUT RD. BOULDER CO 80301
Business Address 6200 LOOKOUT RD. BOULDER CO 80301 720.643.5200
Viridian Therapeutics, Inc.\DE (Filer) CIK: 0001590750 (see all company filings)

IRS No.: 471187261 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-36483 | Film No.: 211019708
SIC: 8071 Services-Medical Laboratories